ATP5A1
Gene Information
- Official Symbol: ATP5F1A
- Official Name: ATP synthase F1 subunit alpha
- Aliases and Previous Symbols: N/A
- Entrez ID: 498
- UniProt: P25705
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, using an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. The catalytic portion of mitochondrial ATP synthase consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled with a stoichiometry of 3 alpha, 3 beta, and a single representative of the other 3. The proton channel consists of three main subunits (a, b, c). This gene encodes the alpha subunit of the catalytic core. Alternatively spliced transcript variants encoding the different isoforms have been identified. Pseudogenes of this gene are located on chromosomes 9, 2, and 16. [provided by RefSeq, Mar 2012].
- UniProt Summary: N/A
Pfam Domains GO Terms
Pfam Domains
| ATP-synt ab |
| ATP-synt ab C |
| ATP-synt ab N |
GO Terms
| proton-transporting ATP synthase complex |
| angiostatin binding |
| mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) |
| mitochondrial proton-transporting ATP synthase complex |
| proton-transporting ATP synthase activity, rotational mechanism |
| MHC class I protein binding |
| mitochondrial ATP synthesis coupled proton transport |
| energy coupled proton transport, down electrochemical gradient |
| ATP synthesis coupled proton transport |
| cristae formation |
| ATP biosynthetic process |
| COP9 signalosome |
| negative regulation of endothelial cell proliferation |
| ADP binding |
| inner mitochondrial membrane organization |
| purine ribonucleoside triphosphate biosynthetic process |
| purine nucleoside triphosphate biosynthetic process |
| ribonucleoside triphosphate biosynthetic process |
| positive regulation of blood vessel endothelial cell migration |
| purine ribonucleoside triphosphate metabolic process |
| transmembrane transporter activity |
| nucleoside triphosphate biosynthetic process |
| ribonucleoside triphosphate metabolic process |
| purine nucleoside triphosphate metabolic process |
| regulation of blood vessel endothelial cell migration |
| mitochondrial transmembrane transport |
| nucleoside triphosphate metabolic process |
| positive regulation of endothelial cell migration |
| oxidative phosphorylation |
| negative regulation of epithelial cell proliferation |
| mitochondrial membrane organization |
| regulation of endothelial cell proliferation |
| positive regulation of epithelial cell migration |
| proton transmembrane transport |
| purine ribonucleotide biosynthetic process |
| purine nucleotide biosynthetic process |
| regulation of endothelial cell migration |
| ribonucleotide biosynthetic process |
| ribose phosphate biosynthetic process |
| purine-containing compound biosynthetic process |
| ATP metabolic process |
| mitochondrial transport |
| regulation of epithelial cell migration |
| ATPase activity |
| nucleotide biosynthetic process |
| nucleoside phosphate biosynthetic process |
| purine ribonucleotide metabolic process |
| ribonucleotide metabolic process |
| purine nucleotide metabolic process |
| regulation of epithelial cell proliferation |
| ribose phosphate metabolic process |
| purine-containing compound metabolic process |
| mitochondrial matrix |
| mitochondrial inner membrane |
| monovalent inorganic cation transport |
| generation of precursor metabolites and energy |
| mitochondrion organization |
| nucleotide metabolic process |
| nucleoside phosphate metabolic process |
| positive regulation of cell migration |
| drug metabolic process |
| positive regulation of cell motility |
| organophosphate biosynthetic process |
| positive regulation of cellular component movement |
| nucleobase-containing small molecule metabolic process |
| positive regulation of locomotion |
| inorganic cation transmembrane transport |
| cation transmembrane transport |
| carbohydrate derivative biosynthetic process |
| inorganic ion transmembrane transport |
| negative regulation of cell population proliferation |
| cation transport |
| regulation of cell migration |
| membrane organization |
| organophosphate metabolic process |
| regulation of cell motility |
| ion transmembrane transport |
| regulation of locomotion |
| regulation of cellular component movement |
| carbohydrate derivative metabolic process |
| nucleobase-containing compound biosynthetic process |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| lipid metabolic process |
| mitochondrion |
| transmembrane transport |
| phosphorylation |
| organic cyclic compound biosynthetic process |
| ion transport |
| RNA binding |
| organonitrogen compound biosynthetic process |
| ATP binding |
| intracellular transport |
| regulation of cell population proliferation |
| cellular nitrogen compound biosynthetic process |
| positive regulation of multicellular organismal process |
| small molecule metabolic process |
| establishment of localization in cell |
| membrane |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| ATP5B | 0.782 |
| ATP5D | 0.776 |
| ATP5O | 0.764 |
| ATP5C1 | 0.693 |
| ATP5L | 0.644 |
| SUPV3L1 | 0.586 |
| ATP5H | 0.582 |
| ATP5F1 | 0.581 |
| HSD17B10 | 0.579 |
| MRPL21 | 0.578 |
| YARS2 | 0.571 |
| ATP5J | 0.571 |
| BCS1L | 0.568 |
| WBSCR16 | 0.565 |
| ATP5E | 0.562 |
| TMEM242 | 0.561 |
| MRPS14 | 0.56 |
| TRIAP1 | 0.555 |
| PPA2 | 0.55 |
| ATP5J2 | 0.549 |
| DAP3 | 0.548 |
| UBE2G2 | 0.54 |
| SLC25A26 | 0.538 |
| ATP5I | 0.537 |
| PARS2 | 0.533 |
| OPA1 | 0.532 |
| DOHH | 0.529 |
| FH | 0.527 |
| MRPS6 | 0.526 |
| ROMO1 | 0.526 |
| COX16 | 0.522 |
| TAZ | 0.518 |
| MRPL23 | 0.516 |
| PNPT1 | 0.516 |
| SCO2 | 0.514 |
| DARS2 | 0.514 |
| HSPD1 | 0.513 |
| TARS2 | 0.509 |
| GATC | 0.508 |
| MRPS11 | 0.505 |
| MRP63 | 0.504 |
| MRPS26 | 0.503 |
| MRPL47 | 0.503 |
| THG1L | 0.502 |
| PMM2 | 0.5 |
| UAP1 | 0.499 |
| GFM1 | 0.499 |
| MRPS21 | 0.499 |
| MRPS16 | 0.497 |
| HCCS | 0.494 |
| MBTPS2 | 0.491 |
| ALG6 | 0.491 |
| TEFM | 0.491 |
| DNLZ | 0.49 |
| SELRC1 | 0.484 |
| VARS2 | 0.484 |
| TAMM41 | 0.483 |
| ALG5 | 0.483 |
| DHRSX | 0.483 |
| COX7B | 0.482 |
| HARS2 | 0.478 |
| ATXN10 | 0.478 |
| ELAC2 | 0.477 |
| UQCRC2 | 0.477 |
| FASTKD5 | 0.474 |
| ADSL | 0.474 |
| NDUFAF4 | 0.473 |
| CYCS | 0.471 |
| SSB | 0.47 |
| KIAA0391 | 0.47 |
| RARS2 | 0.47 |
| PGM3 | 0.47 |
| GFPT1 | 0.468 |
| UBA5 | 0.467 |
| MRPS18A | 0.467 |
| SLC25A3 | 0.464 |
| NDUFA3 | 0.464 |
| TMEM41B | 0.463 |
| TUFM | 0.462 |
| MRPS34 | 0.461 |
| SARS2 | 0.46 |
| NARS2 | 0.456 |
| PGS1 | 0.455 |
| EARS2 | 0.454 |
| C10orf2 | 0.454 |
| DPAGT1 | 0.453 |
| KDSR | 0.453 |
| CASP9 | 0.452 |
| NDUFC2 | 0.451 |
| PDSS1 | 0.45 |
| MRPS23 | 0.45 |
| MRPL20 | 0.449 |
| MRPL53 | 0.448 |
| MRPS5 | 0.447 |
| GTF3C6 | 0.446 |
| C17orf89 | 0.446 |
| CBFB | 0.445 |
| QRSL1 | 0.444 |
| ENY2 | 0.443 |
| CEPT1 | 0.442 |
| URM1 | 0.442 |
| COX15 | 0.442 |
| RPP21 | 0.441 |
| CRLS1 | 0.44 |
| FAF2 | 0.44 |
| HIST1H2BK | 0.439 |
| RBFA | 0.438 |
| LARS2 | 0.437 |
| GTPBP10 | 0.436 |
| NDUFB5 | 0.435 |
| ALG1 | 0.435 |
| SEC62 | 0.433 |
| C14orf2 | 0.433 |
| NDUFB1 | 0.431 |
| MRPS33 | 0.431 |
| MRPL15 | 0.43 |
| APAF1 | 0.43 |
| SLC25A52 | 0.429 |
| VEZT | 0.428 |
| MRPS10 | 0.425 |
| MRPL41 | 0.425 |
| SDHA | 0.425 |
| NDUFAF7 | 0.424 |
| NDUFB3 | 0.424 |
| MTRF1L | 0.424 |
| PLAA | 0.424 |
| PGGT1B | 0.423 |
| RTN4IP1 | 0.423 |
| PPCS | 0.423 |
| NDUFA1 | 0.423 |
| RPE | 0.422 |
| NDUFB11 | 0.422 |
| C1orf27 | 0.422 |
| EXOC4 | 0.422 |
| MRPS9 | 0.421 |
| DOLK | 0.421 |
| RPUSD4 | 0.421 |
| TIMM13 | 0.421 |
| ELP3 | 0.42 |
| BAK1 | 0.42 |
| DNAJC3 | 0.419 |
| LSM11 | 0.419 |
| MRPS25 | 0.417 |
| MARS2 | 0.416 |
| PPP6C | 0.416 |
| GMPPB | 0.414 |
| TRNT1 | 0.413 |
| SRP14 | 0.411 |
| RPTOR | 0.411 |
| EIF3F | 0.41 |
| FTSJ2 | 0.41 |
| MRPS2 | 0.409 |
| MRPL45 | 0.409 |
| TRMT10A | 0.409 |
| LSM10 | 0.409 |
| RNMT | 0.406 |
| GFM2 | 0.405 |
| ALG13 | 0.405 |
| RNASEH1 | 0.403 |
| NDUFV1 | 0.402 |
| RTCB | 0.402 |
| C12orf65 | 0.401 |
| RPIA | 0.401 |
| TRUB2 | 0.4 |
| COQ3 | 0.4 |
| TMED10 | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 13/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 1/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 1/33 |
| central nervous system | 1/56 |
| cervix | 1/4 |
| colorectal | 2/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 1/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 1/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 648
- Expression level (log2 read counts): 9.1
Expression Distribution
ATP5A1 Expression in NALM6 Cells: 9.1